New Approaches to Tuberculosis - Novel Drugs Based on Drug Targets Related to Toll-Like Receptors in Macrophages

Nov 20, 2013Current pharmaceutical design

New tuberculosis drugs targeting immune sensors in infection-fighting cells

AI simplified

Abstract

Developing novel anti-TB drugs targeting virulence factors may be crucial for combating tuberculosis.

Current anti-TB drugs primarily target bacterial metabolic reactions and essential cell components.
New drug development efforts should focus on mycobacterial factors that help MTB survive and replicate inside host macrophages.
Virulence factors that interfere with signaling pathways in host macrophages could create favorable conditions for MTB growth.
Research on drug targets related to Toll-like receptors in MTB is ongoing and may lead to innovative treatments.

AI simplified

Tuberculosis (TB) is one of the most important health concerns in the world, causing serious levels of morbidity and mortality, particularly in many developing countries. Unfortunately, the development of new anti-TB drugs with superior chemotherapeutic and prophylactic activity has been very slow. Thus, it is urgently necessary to develop novel kinds of antituberculosis drugs that exert their anti-Mycobacterium tuberculosis (MTB) activity through unique drug targets expressed by MTB organisms. At present, the drug targets of most current anti-TB drugs are primarily bacterial metabolic reactions and cell components that are indispensable to the growth and survival of MTB organisms in extracellular milieus, particularly in culture media. To develop novel and unique anti-TB drugs in the future, it is desirable to highlight the drug targets related to the bacterial ability to survive and replicate in host macrophages by escaping from a macrophage's bacterial killing mechanism during infection inside such phagocytes. For this purpose, it is reasonable to focus our research efforts on mycobacterial virulence factors that cross-talk and interfere with signaling pathways of host macrophages, because such virulence factors will provide intracellular milieus favorable to intramacrophage survival and growth of MTB. In this chapter, based on such a viewpoint and strategy, the present status of worldwide research on novel potential drug targets related to Toll-like receptor in the MTB pathogen will be described.

Full Text

Full text is available at the source.

View full text ↗

Abstract

Full Text

Related papers

what lands in your inbox each week: